Cargando…
Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
Autores principales: | Zhang, Jie, Tian, Chen, Lv, Fang, Wang, Jianfei, Han, Wenbo, Nie, Jun, Dai, Ling, Hu, Weiheng, Chen, Xiaoling, Ma, Xiangjuan, Tian, Guangming, Wu, Di, Han, Sen, Wang, Yang, Long, Jieran, Zhang, Ziran, Fang, Jian, Zhang, Henghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472086/ https://www.ncbi.nlm.nih.gov/pubmed/30999954 http://dx.doi.org/10.1186/s40880-019-0363-y |
Ejemplares similares
-
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
por: Wang, Yang, et al.
Publicado: (2018) -
Salvage treatment with anlotinib for advanced non‐small cell lung cancer
por: Wu, Di, et al.
Publicado: (2019) -
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer
por: Wu, Di, et al.
Publicado: (2020) -
Prognostic factor analysis of patients with small cell lung cancer: Real‐world data from 988 patients
por: Ma, Xiangjuan, et al.
Publicado: (2021) -
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China
por: Chen, Xiaoling, et al.
Publicado: (2021)